Funded Tech Companies
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical, based in Novato, received equity investments through Sanofi-Genzyme BioVentures, Shire Pharmaceuticals and Adage Capital Management.
Company Overview
Company Name
Ultragenyx Pharmaceutical
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
60 Leveroni Ct.
Novato, CA 94949
USA
Novato, CA 94949
USA
Phone
Website
Email Address
Company Background Information
Overview
Ultragenyx (NASDAQ: RARE) is focused on developing therapeutics for rare diseases. The company will build on management's experience in choosing and developing products with clear mechanisms of action in untreated rare diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/31/2014
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Emil Kakkis
Chief Financial Officer
Shalini Sharp
Chief Operating Officer
John Pinion
VP - Bus. Development
Thomas Kassberg
Company Investors
- Sanofi-Genzyme BioVentures
- Shire Pharmaceuticals
- Adage Capital Management
- BlackRock
- TPG Biotech (Eran Nadav)
- Healthcap Venture Capital
- Pappas Ventures
- F-Prime Capital (Benjamin Auspitz)
- T. Rowe Price
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs